Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Gainers
FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.
B of A Securities Initiates Coverage On IGM Biosciences with Buy Rating, Announces Price Target of $34
B of A Securities analyst Geoff Meacham initiates coverage on IGM Biosciences (NASDAQ:IGMS) with a Buy rating and announces Price Target of $34.
Truist Securities Maintains Buy on IGM Biosciences, Lowers Price Target to $37
Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and lowers the price target from $74 to $37.
IGM Biosciences: Q2 Earnings Insights
IGM Biosciences (NASDAQ:IGMS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:10 PM.
Here's what investors need to know about the announcement.
Baird Maintains Outperform on IGM Biosciences, Lowers Price Target to $31
Baird analyst Joel Beatty maintains IGM Biosciences (NASDAQ:IGMS) with a Outperform and lowers the price target from $46 to $31.
HC Wainwright & Co. Maintains Buy on IGM Biosciences, Lowers Price Target to $58
HC Wainwright & Co. analyst Robert Burns maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and lowers the price target from $59 to $58.
Baird Maintains Outperform on IGM Biosciences, Lowers Price Target to $46
Baird analyst Joel Beatty maintains IGM Biosciences (NASDAQ:IGMS) with a Outperform and lowers the price target from $65 to $46.